300 related articles for article (PubMed ID: 27557887)
1. Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression.
de Oliveira Bravo M; Carvalho JL; Saldanha-Araujo F
Purinergic Signal; 2016 Dec; 12(4):595-609. PubMed ID: 27557887
[TBL] [Abstract][Full Text] [Related]
2. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
[TBL] [Abstract][Full Text] [Related]
3. Reply: Adenosine Producing Mesenchymal Stromal Cells.
Kerkelä E
Stem Cells; 2017 Jun; 35(6):1649-1650. PubMed ID: 27862653
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes.
Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Covas DT; Zago MA; Panepucci RA
Stem Cell Res; 2011 Jul; 7(1):66-74. PubMed ID: 21546330
[TBL] [Abstract][Full Text] [Related]
5. CD73 Pathway Contributes to the Immunosuppressive Ability of Mesenchymal Stem Cells in Intraocular Autoimmune Responses.
Chen X; Shao H; Zhi Y; Xiao Q; Su C; Dong L; Liu X; Li X; Zhang X
Stem Cells Dev; 2016 Feb; 25(4):337-46. PubMed ID: 26650818
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical Regulation of Allogeneic Bone Marrow Engraftment and Immune Privilege by Mesenchymal Cells and Adenosine.
Kakiuchi M; Hirata Y; Robson SC; Fujisaki J
Transplant Cell Ther; 2021 Jan; 27(1):92.e1-92.e5. PubMed ID: 32961376
[TBL] [Abstract][Full Text] [Related]
7. Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.
Zhang JM; Feng FE; Wang QM; Zhu XL; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
Stem Cells Transl Med; 2016 Dec; 5(12):1631-1643. PubMed ID: 27471307
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
9. Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling.
Mokarizadeh A; Delirezh N; Morshedi A; Mosayebi G; Farshid AA; Mardani K
Immunol Lett; 2012 Sep; 147(1-2):47-54. PubMed ID: 22705267
[TBL] [Abstract][Full Text] [Related]
10. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.
Deaglio S; Dwyer KM; Gao W; Friedman D; Usheva A; Erat A; Chen JF; Enjyoji K; Linden J; Oukka M; Kuchroo VK; Strom TB; Robson SC
J Exp Med; 2007 Jun; 204(6):1257-65. PubMed ID: 17502665
[TBL] [Abstract][Full Text] [Related]
11. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
[TBL] [Abstract][Full Text] [Related]
12. Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis.
Zuo D; Liu X; Shou Z; Fan H; Tang Q; Duan X; Cao D; Zou Z; Zhang L
Int J Mol Med; 2013 Dec; 32(6):1337-44. PubMed ID: 24142133
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function.
Sivanathan KN; Rojas-Canales DM; Hope CM; Krishnan R; Carroll RP; Gronthos S; Grey ST; Coates PT
Stem Cells; 2015 Sep; 33(9):2850-63. PubMed ID: 26037953
[TBL] [Abstract][Full Text] [Related]
15. Extracellular adenosine metabolism in immune cells in melanoma.
Umansky V; Shevchenko I; Bazhin AV; Utikal J
Cancer Immunol Immunother; 2014 Oct; 63(10):1073-80. PubMed ID: 24756420
[TBL] [Abstract][Full Text] [Related]
16. Foxp3+CD4+ T cell-mediated immunosuppression involves extracellular nucleotide catabolism.
Bynoe MS; Viret C
Trends Immunol; 2008 Mar; 29(3):99-102. PubMed ID: 18258482
[TBL] [Abstract][Full Text] [Related]
17. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.
Clayton A; Al-Taei S; Webber J; Mason MD; Tabi Z
J Immunol; 2011 Jul; 187(2):676-83. PubMed ID: 21677139
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation.
Sattler C; Steinsdoerfer M; Offers M; Fischer E; Schierl R; Heseler K; Däubener W; Seissler J
Cell Transplant; 2011; 20(8):1221-30. PubMed ID: 21176405
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism.
Yan Z; Zhuansun Y; Chen R; Li J; Ran P
Exp Cell Res; 2014 May; 324(1):65-74. PubMed ID: 24681107
[TBL] [Abstract][Full Text] [Related]
20. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
